These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 6876766)

  • 1. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic phenomenon in leprosy.
    Jadhav VH; Jadhav MV; Sapatnekar SM; Joshi PB
    Indian J Lepr; 1990; 62(2):208-14. PubMed ID: 2212736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lysozyme in leprosy.
    Naik SS; Gurnani S
    Lepr India; 1980 Oct; 52(4):501-7. PubMed ID: 7464056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of patients with erythema nondosum leprosum syndrome.
    Dutta RK
    Lepr India; 1979 Apr; 51(2):209-12. PubMed ID: 480911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
    Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
    Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of serum fibrinolytic activity in leprosy.
    Sharda DP; Parvez M; Jain AK; Bhargava NC; Misra SN
    Lepr India; 1979 Apr; 51(2):203-8. PubMed ID: 480910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
    Bansal F; Narang T; Dogra S; Vinay K; Chhabra S
    Indian J Dermatol Venereol Leprol; 2018; 84(5):573-577. PubMed ID: 28656911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
    Mathur NK; Bumb RA; Mangal HN
    Lepr India; 1983 Jul; 55(3):547-52. PubMed ID: 6656212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors activity in lepromatous leprosy and lepra reaction.
    Yemul VL; Sengupta SR; Dhole TN
    Lepr India; 1983 Jan; 55(1):91-4. PubMed ID: 6603564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.